CClinicalTrials.gg
Sign In
Not yet recruitingNCT07558239Updated Apr 30, 2026

Carotid Intima-media Thickness in Dialysis Patients and Traditional Risk Factors

An observational study in Dialysis Patients, Hypertension and Atherosclerosis, sponsored by Minia University. Not yet recruiting. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-04-30.

Sponsored by Minia University · Observational

From the registry’s dates

  • Primary completion was expected by Jul 2026, 3 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
18 Years to 70 Years
Sex
All
01

Study summary

  • Cardiovascular disease (CVD) is the leading cause of mortality in hemodialysis (HD) patients.
  • Carotid intima-media thickness (CIMT) is a validated surrogate marker for atherosclerosis.
  • Both traditional cardiovascular risk factors (hypertension, diabetes, dyslipidemia) and dialysis-specific factors (mineral metabolism disorders, dialysis duration) contribute to vascular damage.
Read the detailed description
  • Cardiovascular disease (CVD) is the leading cause of mortality in hemodialysis (HD) patients.
  • Carotid intima-media thickness (CIMT) is a validated surrogate marker for atherosclerosis.
  • Both traditional cardiovascular risk factors (hypertension, diabetes, dyslipidemia) and dialysis-specific factors (mineral metabolism disorders, dialysis duration) contribute to vascular damage.
  • Gap in knowledge: Few studies have comprehensively assessed the combined impact of these factors on CIMT in HD patients.
02

Conditions studied

  • Dialysis Patients
  • Hypertension
  • Atherosclerosis

Keywords

  • Renal dialysis
  • Carotid intima- media thickness
03

In context

Hypertension

6,689 studies on the registry are indexed under Hypertension; 965 are open to participants now.

This study's planned enrollment of 100 is below the median of 210 across 1,359 observational studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

Minia University is the lead sponsor of 356 studies on the registry; 115 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Renal dialysis patients

Inclusion criteria

  • 1. Age 18 or older. 2. Patients with sepsis without AKI at the time of admission.

Exclusion criteria

Exclusion Criteria:

  • o Active malignancy

    • Acute infections
    • Recent cardiovascular events (\<3 months)
    • Poor echocardiographic window for CIMT measurement
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Interventions

  • OtherUltrasound measurements of carotid intima- media thickness

    Ultrasound measurements of carotid intima- media thickness

06

What researchers measure

Primary outcomes

  1. • To determine the association between carotid intima - media thickness and: o Hypertension duration o HbA1c o LDL/HDL ratio o Dialysis duration o Parathyroid hormone (PTH) levels

    Time frame: 6 month

Secondary outcomes

  1. • To compare CIMT between: o Diabetics vs. non-diabetics o Short (<5 yrs) vs. long (≥5 yrs) dialysis duration o Patients with vs. without hyperparathyroidism (PTH >300 pg/m

    Time frame: 6month

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • https://doi.org/10.1016/j.atherosclerosis.2019.06.560

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07558239
Lead sponsor
Minia University
Responsible party
Sohair Adeeb (Assistant professor, Minia University) — Principal investigator
First posted
Apr 30, 2026
Start date
Apr 24, 2026 (estimated)
Primary completion
Jul 1, 2026 (estimated)
Completion
Jul 1, 2026 (estimated)
Last update
Apr 30, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Hypertension→

Other studies from this sponsor

Minia University

Start the discussion